Revue medicale de Liege 2012-03-01

[Zoely, a combined oral contraceptive, monophasic pill containing estradiol and nomegestrol acetate].

A Pintiaux, U Gaspard, M Nisolle

Index: Rev. Med. Liege. 67(3) , 152-6, (2012)

Full Text: HTML

Abstract

A new combined oral contraceptive called Zoely has just been marketed in Belgium. It contains nomegestrol acetate, a progestin known for its high contraceptive reliability based on its antigonadotropic power and long half-life. This progestin is associated with estradiol and Zoely is devoid of ethinyl estradiol, which is the usual component of the majority of combined oral contraceptives and is primarily responsible for thrombotic side effects of the pill. The compositon and type of regimen of this new oral contraceptive contribute to its efficacy and excellent clinical tolerance.

Related Compounds

  • Nomegestrol acetat...

Related Articles:

Changing convention in combination oral contraceptives: estradiol and nomegestrol acetate in a monophasic 24/4 regimen.

2013-07-01

[J. Fam. Plann. Reprod. Health Care 39(3) , 211-6, (2013)]

A new contraceptive pill containing 17β-estradiol and nomegestrol acetate.

2013-01-01

[Womens. Health (Lond. Engl.) 9(1) , 13-23, (2013)]

The “newer” progestogens and postmenopausal hormone therapy (HRT)

2014-07-01

[J. Steroid Biochem. Mol. Biol. 142 , 48-51, (2014)]

Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17β-estradiol (NOMAC/E2): a double-blind, randomized study.

2011-06-01

[Hum. Reprod. 26(6) , 1338-47, (2011)]

Inhibition of ovulation by NOMAC/E2, a novel monophasic oral contraceptive combining nomegestrol acetate and 17β-oestradiol: a double-blind, randomised, dose-finding pilot study.

2011-04-01

[Eur. J. Contracept. Reprod. Health Care 16(2) , 76-84, (2011)]

More Articles...